A significant breakthrough in cancer research is arising with the use of mini-antibodies to restore mutated p53. This crucial tumor inhibitor protein is frequently disabled in various kinds of tumors, leading https://bookmarkpath.com/story21928426/nanobodies-reactivate-tumor-suppressor-p53-the-promising-pathway-for-malignant-treatment